The Patient Signal – Details, episodes & analysis

This episode moves from brand strategy to public health strategy, and shows how leadership choices ripple through both worlds. We start with Kenvue’s global agency shakeup, bringing WPP and Publicis into clearly defined lanes as the company looks to streamline execution and push growth across a $1.6B ad footprint. Then we zoom out to 2026’s vaccine reality: mandates, access, and the race to develop new vaccines, all colliding with politics, logistics, and trust.

From there, we connect the dots to a year of medtech turbulence: lawsuits, ERP failures, M&A, leadership turnovers, layoffs, and regulatory pressure shaping how companies operate. Finally, we end with a concrete medical milestone: the first FDA-approved treatment for TA-TMA, a rare and severe complication after stem cell transplants, and what it signals about the future of targeted therapies.

In this episode: • Why Kenvue’s partner model matters for speed, accountability, and scale • What vaccine policy fights reveal about trust and governance • The medtech stories that defined 2025’s risk landscape • A breakthrough FDA approval that could change outcomes for transplant patients

Thanks for listening to this episode. We also discuss the challenges facing vaccine policy in 2026, including debates over mandates, distribution to underserved communities, and the development of new vaccines for emerging diseases.

In the medtech industry, 2025 was marked by significant changes, such as Zimmer Biomet's lawsuit against Deloitte and Johnson & Johnson's major acquisitions. Leadership shifts and strategic refocusing were prevalent, with companies like Olympus and Medtronic adapting to evolving market demands.

Finally, we highlight Omeros's groundbreaking FDA-approved treatment for a severe stem cell transplant complication, showcasing the potential of targeted therapies in addressing complex medical challenges.

Join us as we navigate these dynamic stories and their implications for the future.

Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture.

As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics.

Start your VoiceStream free trial today!

Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources:

• https://www.mmm-online.com/news/kenvue-assigns-global-creative-duties-to-wpp-and-media-to-publicis/
• https://www.statnews.com/2025/12/26/best-of-2025-health-science-biotech/
• https://www.massdevice.com/the-10-most-read-medtech-news-stories-of-2025/
• https://medcitynews.com/2025/12/fatal-complication-of-stem-cell-transplants-gets-its-first-fda-approved-therapy/

Welcome to the Legaltech News Podcast, where we delve into the dynamic intersection of law and technology. Stay informed with our expert analysis on the latest trends in legal tech, from AI integration in legal processes to tackling cybersecurity threats. Discover how legal departments can boost efficiency and cut costs, while law firms enhance client services with innovative tools. We also spotlight tech companies driving change in the legal sector.

In today's episode, we explore Dr. Thomas Kelly's inspiring journey from medicine to legaltech innovation. After leaving his medical career, Kelly developed AI tools like Heidi, an AI medical scribe, to ease doctors' administrative burdens. His venture has attracted significant funding, highlighting AI's transformative potential in traditional fields.

Join us as we provide the insights you need to navigate the rapidly evolving legal tech landscape and make informed decisions.

Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture.

As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics.

Start your VoiceStream free trial today!

Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources:

• https://www.law.com/2025/12/24/health-care-and-life-science-stakeholders-value-ai-for-regulatory-monitoring/
• https://www.cnbc.com/2025/12/24/he-left-medicine-to-build-an-ai-tool-now-its-worth-460-million.html

AI in Life Sciences is a cutting-edge podcast, offering you the latest insights into the application of artificial intelligence in the life sciences sector. This week we delve into Integra LifeSciences' lucrative acquisition of Acclarent, a pioneer in ENT surgical interventions, looking at the diverse market opportunities that this presents. We also discuss the role of quality data in improving the effectiveness of AI models in healthcare. The podcast features an insightful segment on the tripartite partnership of Otsuka Pharmaceutical, Click Therapeutics, and the FDA leading to the clearance of a new digital therapeutic for major depressive disorder. Our episode also examines the National Institutes of Health's initiative to fund the development of AI tools to aid health disparity research. We explore how AI is potentially transforming healthcare, and how we need to prepare healthcare professionals to leverage these advancements. Finally, we delve into how innovative technology and automation, led by Norbert Health's AI sensing hub, are changing the face of elder care. Tune in for these exciting developments and much more.

In a groundbreaking project, doctors in Africa use AI to fight against diseases such as malaria, HIV/AIDS, and tuberculosis, causing a stir in the medical community. This innovative application of AI in diagnosis and treatment of such prevalent diseases might change the game in global health maintenance. - Lastly, we delve into the intersection of genetics and AI, exploring how researchers are making significant strides in understanding and predicting genetic diseases. A fascinating new project in the US combines machine learning and genetics to predict a family's health risk for illnesses like cancer and heart disease. "AI in Life Sciences" presents these significant developments and ongoing issues in AI applications in medical and health fields around the globe. Tune in to explore the future of health, medicine, and technology.

On the latest episode of "AI in Life Sciences," we engage with the impressive multimodal, AI-driven technology patented by Openstream.ai. This technology promises to revolutionize operational efficiency across multiple sectors with its advanced capabilities. Also, we discuss a breakthrough in the biopharma industry - an AI platform capable of identifying promising early-stage assets and firms. We also delve into the pressing need for the integration of AI technology in the healthcare sector for improved patient care and operational efficiency. We round up the episode examining the implications of Novo's $1 billion deal in the field of cardiovascular medicine, a move that could redefine the cardiac treatment landscape. Tune in for these exciting insights and more.

"AI in Life Sciences" is a podcast offering a comprehensive view into how artificial intelligence transforms the healthcare and life sciences sector. This week, we unpack new research from HFS and Cognizant that emphasizes the role of GenAI in bridging the understanding gap between health plans and providers for improved patient outcomes. We discuss Kooth Digital Health's partnership with Aetna for adolescent mental health services in Illinois, and Verix's game-changing GenAI Database Explorer for pharma industry insights. We introduce CentralReach's inaugural Head of GenerativeAI, David Stevens, and his task to enhance CentralReach's software with GenAI features. We forecast the future role of autonomous inpatient coding in revenue cycle management and its expected launch by 2024. We reveal Brightside Health’s recent successful funding round enabling a wider reach of its remote mental health services. Finally, we highlight the potential intellectual property security threats from WuXi AppTec's alleged ties with the Chinese government. Tune in to stay informed about AI's transformative role in life sciences.

"AI in Life Sciences" is an enlightening podcast focusing on the exponential impact of artificial intelligence in the healthcare industry. In this episode, we explore how California's Sutter Health and AI firm Abridge are partnering to streamline clinical documentation and improve patient understanding. We also delve into GE Healthcare's latest AI tool, Prostate Volume Assist, designed to accelerate prostate volume measurements and facilitate early prostate cancer diagnoses. Additional highlights include Nebraska Medicine's use of AI to reduce nurse turnover, Blackstone's hefty investment in Moderna's influenza program, and the role of Health Information Exchange Networks in enhancing patient care and promoting health equity. Stay tuned for these insightful stories illustrating the transformative power of AI in advancing life sciences.

"AI in Life Sciences" is a podcast that dives into the latest happenings and innovations in the life sciences industry. In today's episode, we discuss Pfizer's decision to end one of its clinical trials focused on a sickle cell treatment, and how it would affect their plans for the drug's approval. We'll also delve into new obesity data from Viking Therapeutics, and how their dual agonist, VK2735, has shown promising results in weight reduction. The importance of high-quality data in AI projects cannot be undervalued, and we take a closer look at how 'data health' is pivotal to the success of AI innovations. Furthermore, we explore a groundbreaking gene therapy by Nanoscope Therapeutics, that is offering hope to millions suffering from retinal diseases. As the Supreme Court deliberates on the in-person dispensing requirement for mifepristone, we consider its potential impact on the biopharma industry and reproductive rights. And lastly, we shed light on the rise of AI-integrated medical devices that are redefining the healthcare sector. Tune in to get the latest updates from the world of life sciences.

On today's episode of AI in Life Sciences, we cover Redi Health's fruitful Series B funding round, and its plans to revolutionize healthcare using tech-integrated solutions. We delve into the groundbreaking use of digital twins powered by AI in cost reduction, advanced disease detection, personalized medicine, and optimization of operations in the healthcare sector. We also introduce NuraLogix's Anura MagicMirror, an innovative smart device that uses facial blood flow data for vital sign calculations and disease risk assessments. Next, we discuss the Children's Hospital Los Angeles's ambient AI assistant, Nabla Copilot, and its role in reducing practitioner stress and improving patient care. We explore the partnership between Neurable and Healthspan Digital, broadening access to the ground-breaking brain-computer interface tech. And finally, we unveil Novo Nordisk's acquisition of Cardior Pharmaceuticals, expanding its cardiometabolic medicine pipeline.

"AI in Life Sciences" explores breakthroughs and trends in the world of medicine and healthcare from a futuristic lens. This episode covers the landmark achievement of Taiwan's Taipei Veterans General Hospital, the first in Asia to win two HIMSS digital maturity awards, setting them apart in using advanced digital technologies for patient care. As pharmacies merge with contemporary medicine management, it investigates the rise of the Chief Pharmacy Officer in hospitals. Lastly, following heightened nationwide debates on abortion rights, it discusses guidance issued by the Texas Medical Board clarifying legal measures for emergency abortions, further outlining its impact on physicians and women's healthcare.